PLX icon

Protalix BioTherapeutics
PLX

Overview Fund Activity

28 hedge funds and large institutions have $19.8M invested in Protalix BioTherapeutics in 2020 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
+9
Holders Change %
+47.37%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
6
Reduced
2
Closed
5
Calls
$1.15M
Puts
$12K
Net Calls
+$1.14M
Net Calls Change
+$1.02M

Top Buyers

1
UOC
1
UBS O'Connor
Illinois
$2.55M
2
PF
2
Phoenix Financial
Israel
$681K
3
Bank of Montreal
3
Bank of Montreal
Ontario, Canada
$615K
4
KCM
4
Kennedy Capital Management
Missouri
$384K
5
EMG
5
ETF Managers Group
New Jersey
$367K

Top Sellers

1
HCM
1
Highbridge Capital Management
New York
$9.15M
2
SG Americas Securities
2
SG Americas Securities
New York
$0
3
Group One Trading
3
Group One Trading
Illinois
$0
4
Victory Capital Management
4
Victory Capital Management
Texas
$0
5
CA
5
Clearstead Advisors
Ohio
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Bank of America
26
Bank of America
North Carolina
$1K +$860 +191 +616%
SG Americas Securities
27
SG Americas Securities
New York
– -$53K -22,500 Closed
Group One Trading
28
Group One Trading
Illinois
– -$14K -5,969 Closed
Victory Capital Management
29
Victory Capital Management
Texas
– -$12K -5,140 Closed
CA
30
Clearstead Advisors
Ohio
– -$1K -500 Closed
1
2